New Hope with Immunotherapy and Targeted Therapy

Cancer is a major global health concern, with experts always looking for more effective and less toxic treatment alternatives. In recent years, targeted therapy and immunotherapy have emerged as viable alternatives to chemotherapy and radiation. These treatments have shown significant improvements in patient outcomes, while their efficacy varies depending on the cancer type and specific patient characteristics.

- 

As the name suggests, targeted therapy is the use of medications or other substances that specifically target cancer cells while causing minimal damage to healthy cells. Immunotherapy, on the other hand, works by activating the immune system to recognize and target cancer cells.

Dr. Parveen Jain, Senior Consultant & HOD - Oncology at Aakash Healthcare: We are now able to tailor treatments based on genetic mutations and immune response offering patients not just better survival but also improved quality of life. We're committed to bringing these innovations into clinical practice where they matter most, at the patient's bedside.

Breakthroughs in Targeted Therapy and Immunotherapy

Targeted therapy has shown significant response rates in tumors with specific genetic alterations, such as EGFR-mutated non-small cell lung cancer and HER2-positive breast cancer. Recent research has centered on creating more precise targeted medicines based on specific genetic abnormalities or biomarkers. For example, a 2023 study found that a new targeted medication for non-small cell lung cancer enhanced progression-free survival when compared to traditional chemotherapy.